Related Experiment Video

Updated: May 19, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma

Cheng-Kui Cai1, Guang-Yi Zhao, Li-Ying Tian

  • 1Department of Orthopedic Surgery Center and Orthopedic Oncology Institute of People's Liberation Army, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, PR China.

Oncology Reports
|August 28, 2012
PubMed

Insights

MicroRNAs miR-15a and miR-16-1 suppress cyclin D1 (CCND1) in osteosarcoma cells. This finding suggests a potential therapeutic strategy targeting CCND1 to inhibit cancer cell proliferation and induce apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Osteosarcoma is a primary bone tumor characterized by rapid proliferation and drug resistance.
  • Cyclin D1 (CCND1) is a key regulator of cell proliferation.
  • Non-coding microRNAs (miRNAs) are critical regulators of gene expression, including CCND1.

Purpose of the Study:

  • To investigate the role of specific miRNAs in regulating CCND1 expression in osteosarcoma.
  • To determine if these miRNAs can induce apoptosis and cell cycle arrest in osteosarcoma cells.
  • To explore the therapeutic potential of miRNA-mediated CCND1 suppression.

Main Methods:

  • Bioinformatic analysis to identify potential miRNA targets of CCND1.
  • Transfection of osteosarcoma cell lines (SOSP-9607) with miR-15a and miR-16-1 mimics.
  • Assessment of cell proliferation, cell cycle progression, and apoptosis.
  • Validation of direct binding of miRNAs to the CCND1 3'-untranslated region (3'-UTR).

Main Results:

  • miR-15a and miR-16-1 were identified as direct regulators of CCND1.
  • Upregulation of miR-15a and miR-16-1 led to decreased CCND1 expression.
  • Transfected osteosarcoma cells exhibited reduced proliferation and cell cycle arrest.
  • miR-15a and miR-16-1 induced apoptosis in osteosarcoma cells.
  • Direct binding of miR-15a and miR-16-1 to the CCND1 3'-UTR was confirmed.

Conclusions:

  • miR-15a and miR-16-1 effectively suppress CCND1 transcription in osteosarcoma.
  • CCND1 plays a significant role in osteosarcoma cell proliferation.
  • Targeting CCND1 with miR-15a and miR-16-1 represents a promising therapeutic avenue for osteosarcoma treatment.

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...